Transcript diversity of Machado-Joseph disease gene (ATXN3) is not directly determined by SNPs in exonic or flanking intronic regions
- PMID: 22706685
- DOI: 10.1007/s12031-012-9832-3
Transcript diversity of Machado-Joseph disease gene (ATXN3) is not directly determined by SNPs in exonic or flanking intronic regions
Abstract
Alternative splicing (AS) of pre-mRNA is an important regulatory mechanism that enables one gene to produce multiple mature transcripts and, therefore, multiple protein isoforms. Besides the information content of core splicing signals, additional cis-regulatory elements (splicing enhancers and silencers) are needed to precisely define exons. AS is well documented in ATXN3 gene, which encodes for ataxin-3 and, when mutated, is responsible for Machado-Joseph disease (MJD). By studying MJD patients and controls, we have previously identified 56 alternative transcript variants for this gene; some were predicted to encode "protective" ataxin-3 isoforms, making then pertinent to understand AS regulation. The present study aims to investigate the relationship between variation in ATXN3 cis-regulatory motifs and AS variants found for each individual. We have sequenced exonic and flanking intronic ATXN3 regions, in genomic DNA from MJD patients and controls previously studied. None of the 10 single nucleotide polymorphisms (SNPs) that were found was located in core splicing signals. In silico analysis showed those SNPs implied losses and gains of recognition motifs for splicing factors. Each particular allele was not directly reflected in alterations of the resulting splicing variants, indicating that AS cannot be determined solely by these cis-elements, but should result from a more complex mode of regulation.
Similar articles
-
Increased transcript diversity: novel splicing variants of Machado-Joseph disease gene (ATXN3).Neurogenetics. 2010 May;11(2):193-202. doi: 10.1007/s10048-009-0216-y. Epub 2009 Aug 28. Neurogenetics. 2010. PMID: 19714377
-
The genomic structure and expression of MJD, the Machado-Joseph disease gene.J Hum Genet. 2001;46(7):413-22. doi: 10.1007/s100380170060. J Hum Genet. 2001. PMID: 11450850
-
Blood and cerebellar abundance of ATXN3 splice variants in spinocerebellar ataxia type 3/Machado-Joseph disease.Neurobiol Dis. 2024 Apr;193:106456. doi: 10.1016/j.nbd.2024.106456. Epub 2024 Feb 27. Neurobiol Dis. 2024. PMID: 38423193
-
[Recent advances in molecular genetics of spinocerebellar ataxia type 3/Machado-Joseph disease].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Dec;25(6):660-2. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008. PMID: 19065526 Review. Chinese.
-
Spastic paraparesis as the first manifestation of Machado-Joseph disease: A case report and review of the literature.Clin Neurol Neurosurg. 2018 Sep;172:137-140. doi: 10.1016/j.clineuro.2018.06.037. Epub 2018 Jul 2. Clin Neurol Neurosurg. 2018. PMID: 30007589 Review.
Cited by
-
Physiological and pathophysiological characteristics of ataxin-3 isoforms.J Biol Chem. 2019 Jan 11;294(2):644-661. doi: 10.1074/jbc.RA118.005801. Epub 2018 Nov 19. J Biol Chem. 2019. PMID: 30455355 Free PMC article.
-
The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases.Biochem J. 2024 Mar 20;481(6):461-480. doi: 10.1042/BCJ20240017. Biochem J. 2024. PMID: 38497605 Free PMC article. Review.
-
ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3.Expert Rev Mol Med. 2024 Sep 25;26:e19. doi: 10.1017/erm.2024.10. Expert Rev Mol Med. 2024. PMID: 39320846 Free PMC article. Review.
-
Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice.Mol Ther Nucleic Acids. 2017 Sep 15;8:232-242. doi: 10.1016/j.omtn.2017.06.019. Epub 2017 Jun 29. Mol Ther Nucleic Acids. 2017. PMID: 28918024 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials